23 studies found for:    Cardiomyopathy | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
Cardiomyopathy | Open Studies | NIH, U.S. Fed (23 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Intervention: Other: None - this is an observational study
2 Recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
3 Not yet recruiting Efficacy and Safety of ICD Implantation in the Elderly
Conditions: Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Optimal standard of care
4 Recruiting Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Conditions: T-cell Acute Lymphoblastic Leukemia;   Intermediate Hodgkins;   Advanced Hodgkins;   Early Hodgkins
Interventions: Other: Diagnostic/symptom checklist;   Other: Anthropometry;   Procedure: Echocardiogram;   Procedure: Serum Biomarkers;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages ≥14 years only)
5 Recruiting Feasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Ischemic Cardiomyopathy
Intervention: Drug: Micronutrients
6 Recruiting Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Condition: Hypertrophic Cardiomyopathy
Interventions: Drug: Valsartan;   Drug: Placebo
7 Recruiting Hypertrophic Regression With N-Acetylcysteine in HCM
Condition: Hypertrophic Cardiomyopathy
Intervention: Drug: N-acetylcysteine (NAC)
8 Recruiting Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
Conditions: Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Inflammation;   Sudden Cardiac Death
Intervention:
9 Recruiting Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
Conditions: Inflammation;   Cancer;   Cardiomyopathy
Intervention:
10 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
11 Unknown  Prevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
Condition: Chagas Disease
Intervention: Procedure: Trypanosoma cruzi serology
12 Recruiting Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring
Conditions: Cardiovascular Disease;   Acute Rejection of Cardiac Transplant;   Cardiac Transplant Rejection;   Heart Transplant Failure and Rejection
Intervention:
13 Recruiting Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial
Condition: Chronic Heart Failure
Intervention: Other: CASA Intervention
14 Recruiting Lipid Biomarkers for Diabetic Heart Disease
Conditions: Type II Diabetes Mellitus;   Diabetes Complications
Interventions: Drug: Fenofibrate;   Drug: Placebo for fenofibrate
15 Recruiting Palliative Care in Heart Failure
Conditions: Heart Failure;   Heart Diseases;   Cardiovascular Diseases
Intervention: Behavioral: Usual heart failure care + interdisciplinary palliative care
16 Recruiting Safety Study of Pyridostigmine in Heart Failure
Condition: Heart Failure
Intervention: Drug: Pyridostigmine Bromide
17 Not yet recruiting Blended Collaborative Care for Heart Failure and Co-Morbid Depression
Conditions: Heart Failure, Systolic;   Depression;   Cardiovascular Disease
Interventions: Behavioral: Collaborative Care for Heart Failure;   Behavioral: Collaborative Care for Depression
18 Recruiting Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Condition: Acute Heart Failure
Interventions: Drug: Liraglutide;   Drug: Placebo
19 Unknown  The Effect of Diet and Exercise in Heart Failure
Conditions: Heart Failure, Congestive;   Metabolic Syndrome X;   Obesity
Intervention: Behavioral: Lifestyle Modification (diet, exercise, and behavior)
20 Recruiting Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
Conditions: Heart Failure With Preserved Ejection Fraction;   Pulmonary Disease;   Left Ventricular Hypertrophy/Hypertension
Interventions: Drug: Dobutamine;   Drug: Amlodipine

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
Indicates status has not been verified in more than two years